Results 171 to 180 of about 41,522 (262)

Canoe full of hot paddlers: TRPV1 neurons steering cardiorespiratory control

The Journal of Physiology, EarlyView.
Richard J. A. Wilson, Nicholas Jendzjowsky   +1 more
wiley   +1 more source

A Humanized Anti‐gD Broadly Neutralizing Antibody Confers Complete Post‐Exposure Protection Against Pseudorabies Virus

Advanced Science, Volume 13, Issue 46, 17 August 2026.
Pseudorabies virus (PRV), an emerging zoonotic α‐herpesvirus, causes life‐threatening human encephalitis. We identified a broad‐spectrum neutralizing antibody 6F7 targeting PRV gD. It blocks gD‐Nectin‐1 binding and membrane fusion, inhibiting replication across all PRV variants, representing a promising candidate for anti‐PRV therapy.
Yue Sun, Jianbo Liu, Shi‐Jia Xu, Meng‐Xin Wang, Hongliang Zhang, Yanhe Zhang, Zhi‐Jun Tian, Jin‐Mei Peng, Xin Yin, Tong‐Qing An, Xue‐Hui Cai, Yan‐Dong Tang   +11 more
wiley   +1 more source

Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). [PDF]

Thorax
Pollock J, Polverino E, Dhar R, Dimakou K, Traversi L, Bossios A, Haworth C, Loebinger MR, De Soyza A, Vendrell M, Burgel PR, Mertsch P, McDonnell MJ, Skgrat S, Maiz-Carro L, Sibila O, van der Eerden M, Kauppi P, Hill AT, Wilson R, Milenkovic B, Menéndez R, Murris M, Crichton ML, Borecki S, Obradovic D, Irfan M, Eshenkulova V, Nowinski A, Amorim A, Torres A, Lorent N, Welte T, Blasi F, Van Braeckel E, Altenburg J, Shteinberg M, Boersma W, Elborn JS, Aliberti S, Ringshausen FC, Goeminne P, Chalmers JD.   +42 more
europepmc   +1 more source

Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence‐Based Expert Review

International Forum of Allergy &Rhinology, Volume 16, Issue 8, Page 852-879, August 2026.
ABSTRACT Background Chronic rhinosinusitis (CRS) is a prevalent, heterogeneous inflammatory disease associated with significant morbidity. Systemic corticosteroids (SCS) are commonly prescribed for their anti‐inflammatory effects, but cumulative exposure carries risks, including metabolic, cardiovascular, and skeletal complications.
Andrew Thamboo, Deanna Gigliotti, Eugenio De Corso, Stella Lee, Benjamin S. Bleier, Christopher J. Chin, Marie‐Noelle Corriveau, Valerie Hox, Claire Hopkins, Peter H. Hwang, Arif Janjua, Ludger Klimek, Daniel Lee, John Lee, Amber Luong, Geoffrey Mortuaire, Joaquim Mullol, Zara M. Patel, John Scott, Doron Sommer, Leigh Sowerby, Marc Tewfik, Beatrice Voizard, Martin Wagenmannm, Sarah K. Wise, Jonathan Yip, Quirina Thompson, Martin Desrosiers, Yvonne Chan   +28 more
wiley   +1 more source

Effects of deprescribing from inhaled corticosteroids in people with cystic fibrosis: protocol for a target trial emulation using the UK CF Registry. [PDF]

BMJ Open
McClenaghan E, Rouette J, Granger E, Davies G, Keogh RH, Tazare J.   +5 more
europepmc   +1 more source

Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiators

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2924-2936, August 2026.
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen, Sean Hennessy, Colleen M. Brensinger, Warren B. Bilker, Laura M. Dember, Todd A. Miano, Tat‐Thang Vo, Allison W. Willis, Charles E. Leonard   +8 more
wiley   +1 more source

Inhaled Corticosteroids and Risk of <i>Staphylococcus aureus</i> Isolation in Bronchiectasis: A Register-Based Cohort Study. [PDF]

J Clin Med
Filipsen AA, Frost KH, Eklöf J, Tønnesen LL, Vognsen AK, Boel JB, Pinholt M, Andersen CØ, Dessau RBC, Biering-Sørensen T, Johansson SL, Jensen JU, Sivapalan P.   +12 more
europepmc   +1 more source

Efficacy and Safety of Corticosteroids in Tuberculous Meningitis: Systematic Review, Meta‐Analysis, and Meta‐Regression

Brain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Background Tuberculous meningitis (TBM) carries a case fatality rate of up to 50% in resource‐limited settings despite standard anti‐tuberculosis therapy. Adjunctive corticosteroids are widely recommended, yet their effect on mortality and safety across diverse populations remains imprecisely defined.
Ayesha Younas, Rizwana Noor, Muhammad Talha Shaukat, Aisha Ijlal, Irra Tariq, Murtaja Satea, Muhammad Sameer Almas, Rosheen Jamil, Mifrah Rahat Khan Sherwani, Norma Nicole Gamarra Valverde, Maria Qadri, Mahwash Siddiqi, Kashif Qureshi, Kivanc Yangi, Bipin Chaurasia   +14 more
wiley   +1 more source

Treatment Persistence and Variations in Prescribing Oral, Injectable, and Inhaled Corticosteroids: A Population-Based Drug Utilisation Study. [PDF]

Pharmacoepidemiol Drug Saf
Domzaridou E, Carr MJ, Williams DM, Avery AJ, van Staa T, Rees DA, Ashcroft DM.   +6 more
europepmc   +1 more source

The effects of inhaled corticosteroids on healthy airways

, 2023
Marchi E, Hinks TS, Richardson M, Khalfaou L, Symon FA, Rajasekar P, Clifford R, Hargadon B, Austin CD, MacIsaac JL, Kobor MS, Siddiqui S, Mar JS, Arron JR, Choy D, Bradding P.   +15 more
europepmc   +1 more source